Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunct tirofiban after mechanical thrombectomy for acute anterior circulation ischemic stroke
ChiCTR2500105242Phase 3Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in brain infarction comparing Tirofiban adjunct treatment with Placebo (2 arms). Primary endpoints: Proportion of patients with mRS 0–2 at 90 days and Proportion of symptomatic intracranial hemorrhage (sICH) within 48 hours (Heidelberg criteria). Started Jul 2025; status: recruiting.
02
Drugs
tirofiban
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2500105242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105242.